Nanoparticles for Cancer Diagnosis and Treatment

Dear Colleagues,

Cancer is the leading cause of death worldwide. Research on early diagnosis will help cure the disease at earlier stages. Chemotherapy is a frequently used treatment option for cancer, but this results in unwanted side effects. Nanotechnology-based targeted delivery of chemotherapeutic agents to cancer cells will ensure better therapeutic outcomes and minimize unwanted side effects. Lipid nanoparticles have been proven to be instrumental in gene therapy for the treatment of cancer and other infectious diseases. Immunotherapy for cancer is another attractive approach to achieve better therapeutic outcomes. In this Special Issue, we will focus on nanoparticle-based strategies for the diagnosis and treatment of cancer.

Dr. Muhammad Muzamil Khan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• lipid nanoparticles
• tumor targeting
• cancer diagnostics
• cancer immunotherapy
• gene therapy